Stock Events

Stock Events

Sonnet Biotherapeutics (SONN) Q3 2024 Earnings

Aug 14Confirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-6.12

-4.06

-1.99

0.07

Details

Expected EPS

-6.12

Actual EPS

-5.6

Surprise EPS

0.52

Surprise Percent

+8.5%

Description

⁨Sonnet Biotherapeutics⁩ (⁦SONN⁩) has reported earnings of ⁦-5.6⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.